EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Reversion of Mycobacterium tuberculosis Immunoreactivity Tests on the Estimated Annual Risk of Tuberculosis Infection

Alvaro Schwalb, Jon C Emery, Katie D Dale, Katherine C Horton, César A Ugarte-Gil, Rein M G J Houben

American Journal of Epidemiology · 2023

DOI: 10.1093/aje/kwad028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Epidemiology, 2023. Verfasst von Alvaro Schwalb und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Latent Tuberculosis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A key metric in tuberculosis epidemiology is the annual risk of infection (ARI), which is usually derived from tuberculin skin test (TST) and interferon-γ release assay (IGRA) prevalence surveys carried out in children. Derivation of the ARI assumes that immunoreactivity is persistent over time; however, reversion of immunoreactivity has long been documented. We used a deterministic, compartmental model of Mycobacterium tuberculosis (Mtb) infection to explore the impact of reversion on ARI estimation using age-specific reversion probabilities for the TST and IGRA. Using empirical data on TST reversion (22.2%/year for persons aged ≤19 years), the true ARI was 2–5 times higher than that estimated from immunoreactivity studies in children aged 8–12 years. Applying empirical reversion probabilities for the IGRA (9.9%/year for youths aged 12–18 years) showed a 1.5- to 2-fold underestimation. ARIs are increasingly underestimated in older populations, due to the cumulative impact of reversion on population reactivity over time. Declines in annual risk did not largely affect the results. Ignoring reversion leads to a stark underestimation of the true ARI in populations and our interpretation of Mtb transmission intensity. In future surveys, researchers should adjust for the reversion probability and its cumulative effect with increasing age to obtain a more accurate reflection of the burden and dynamics of Mtb infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosisLatent TuberculosisChildAdolescentHumansAgedInterferon-gamma Release TestsTuberculin Test

Stichwörter der Autor:innen

Mycobacterium tuberculosis transmissionTST/IGRA surveysinterferon-γ release assaytuberculin skin testtuberculosis

Zitieren

APA

Schwalb, A., Emery, J. C., Dale, K. D., Horton, K. C., Ugarte-Gil, C. A., & Houben, R. M. G. J. (2023). Impact of Reversion of Mycobacterium tuberculosis Immunoreactivity Tests on the Estimated Annual Risk of Tuberculosis Infection. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwad028

Vancouver

Schwalb A, Emery JC, Dale KD, Horton KC, Ugarte-Gil CA, Houben RMGJ. Impact of Reversion of Mycobacterium tuberculosis Immunoreactivity Tests on the Estimated Annual Risk of Tuberculosis Infection. American Journal of Epidemiology. 2023. doi:10.1093/aje/kwad028

BibTeX
@article{Schwalb2023,
  author = {Schwalb, Alvaro and Emery, Jon C and Dale, Katie D and Horton, Katherine C and Ugarte-Gil, César A and Houben, Rein M G J},
  title = {Impact of Reversion of Mycobacterium tuberculosis Immunoreactivity Tests on the Estimated Annual Risk of Tuberculosis Infection},
  journal = {American Journal of Epidemiology},
  year = {2023},
  doi = {10.1093/aje/kwad028}
}
Kostenlos starten →